+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infectious Disease Drug"

FOSMANOGEPIX - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

FOSMANOGEPIX - Emerging Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
REZAFUNGIN - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

REZAFUNGIN - Emerging Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
Infectious Disease Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Infectious Disease Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Veterinary Infectious Disease Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Veterinary Infectious Disease Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Pseudomonas aeruginosa Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Pseudomonas aeruginosa Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 153 Pages
  • Global
From
Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 257 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2022

  • Clinical Trials
  • January 2022
  • 244 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 224 Pages
  • Global
From
Onychomycosis (Tinea Unguium) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Onychomycosis (Tinea Unguium) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • August 2021
  • 160 Pages
  • Global
From
Aspergillosis Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Aspergillosis Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • June 2020
  • 183 Pages
  • Global
From
Community Acquired Pneumonia Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Community Acquired Pneumonia Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • February 2020
  • 325 Pages
  • Global
From
Tinea Pedis (Athlete Foot) Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Tinea Pedis (Athlete Foot) Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • January 2020
  • 91 Pages
  • Global
From
Influenzavirus B Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Influenzavirus B Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • December 2022
  • 235 Pages
  • Global
From
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • November 2022
  • 246 Pages
  • Global
From
Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • July 2022
  • 452 Pages
  • Global
From
Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 136 Pages
  • Global
From
Onychomycosis (Tinea Unguium) Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Onychomycosis (Tinea Unguium) Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • February 2021
  • 154 Pages
  • Global
From
Sepsis Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Sepsis Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 586 Pages
  • Global
From
Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 71 Pages
  • Global
From
Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 86 Pages
  • Global
From
Loading Indicator

The Infectious Disease Drug market is a subset of the pharmaceutical industry that focuses on the development and production of drugs to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from bacterial and viral infections to fungal and parasitic diseases. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. They also work to ensure that their drugs are safe and effective. Some of the major players in the Infectious Disease Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Johnson & Johnson, and AstraZeneca. These companies are involved in the research, development, and production of drugs to treat a variety of infectious diseases. Show Less Read more